Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Metrics to compare | MEDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDAPeersSector | |
---|---|---|---|---|
P/E Ratio | 266.7x | 18.1x | −0.5x | |
PEG Ratio | 0.58 | −0.09 | 0.00 | |
Price / Book | 3.5x | 2.4x | 2.6x | |
Price / LTM Sales | 4.2x | 3.5x | 3.0x | |
Upside (Analyst Target) | 21.7% | 27.5% | 55.2% | |
Fair Value Upside | Unlock | 15.3% | 9.7% | Unlock |